Survi Pharmaceutical Private Limited, a active private limited company, was established on 20 March 2015 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909WB2015PTC205716. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Tukeshwar Dutta Sinha (Director), Sarita Dutta Sinha (Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 243/1, Sahid Hemanta Kumar Basu Sarani, Kolkata, West Bengal, 700074.
U51909WB2015PTC205716
205716
20 March 2015
₹1.00 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Survi Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tukeshwar Dutta Sinha | Director | 20 Mar 2015 | Current |
| Sarita Dutta Sinha | Director | 20 Mar 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Survi Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 54.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Survi Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2025 | State Bank Of India | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Survi Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Survi Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Survi Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 101085268 was registered on 31 Mar 2025. was documented.
Survi Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Survi Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
The activity Tukeshwar Dutta Sinha was appointed as a Director was appointed as a Director on 20 Mar 2015 & has been associated with this company since 10 years 9 months . was completed.
Sarita Dutta Sinha was appointed as a Director was appointed as a Director on 20 Mar 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.
The activity Survi Pharmaceutical Private Limited was registered on 20 Mar 2015 with Roc Kolkata & aged 10 years 9 months as per MCA records. was completed.
The CIN of Survi Pharmaceutical Private Limited is U51909WB2015PTC205716.
Survi Pharmaceutical Private Limited is headquartered at 243/1, Sahid Hemanta Kumar Basu Sarani, Kolkata, West Bengal, 700074.
Survi Pharmaceutical Private Limited was incorporated on 20 March 2015.
The current directors of Survi Pharmaceutical Private Limited are
The primary industry of Survi Pharmaceutical Private Limited is Pharma.
Survi Pharmaceutical Private Limited is unlisted.
The authorized capital of Survi Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Survi Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX